Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Severe Cardiac Toxicity Induced by Cancer Therapies Requiring Intensive Care Unit Admission

Published:2021-09-03 Issue: Volume:8 Page:
ISSN:2297-055X
Container-title:Frontiers in Cardiovascular Medicine
language:
Short-container-title:Front. Cardiovasc. Med.

Author:

Montisci Andrea,Palmieri Vittorio,Liu Jennifer E.,Vietri Maria T.,Cirri Silvia,Donatelli Francesco,Napoli Claudio

Abstract

Graphical Abstract

Funder

Università degli Studi di Milano

Publisher

Frontiers Media SA

Subject

Cardiology and Cardiovascular Medicine

Reference151 articles.

1. Adverse cardiac effects of cancer therapies: cardiotoxicity and arrhythmia;Herrmann;Nat Rev Cardiol.,2020

2. Cardiovascular toxicity related to cancer treatment: a pragmatic approach to the american and european cardio-oncology guidelines;Alexandre;J Am Heart Assoc.,2020

3. A new anticancer drug with significant clinical activity;Blum;Ann Intern Med.,1974

4. Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II;Tewey;Science.,1984

5. Topoisomerase II beta-mediated DNA double-strand breaks: implications in doxorubicin cardiotoxicity and prevention by dexrazoxane;Lyu;Cancer Res.,2007

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current approaches in tissue engineering-based nanotherapeutics for osteosarcoma treatment;Biomedical Materials;2024-02-26

2. Stem Cell Therapies for the Treatment of Radiation and Chemotherapy Side Effects;Comprehensive Hematology and Stem Cell Research;2024

3. DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling;Drug Discovery Today;2023-11

4. DICTrank: The largest reference list of 1318 human drugs ranked by risk of drug-induced cardiotoxicity using FDA labeling;2023-07-07

5. Cardiotoxicity, Cardioprotection, and Prognosis in Survivors of Anticancer Treatment Undergoing Cardiac Surgery: Unmet Needs;Cancers;2023-04-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3